AB Large Cap Value Fund
Name
As of 07/24/2026Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
20.7%
1 yr return
31.9%
3 Yr Avg Return
18.9%
5 Yr Avg Return
13.5%
Net Assets
$529 M
Holdings in Top 10
30.7%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.89%
SALES FEES
Front Load 4.25%
Deferred Load N/A
TRADING FEES
Turnover 42.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$2,500
IRA
$2,500
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 07/24/2026Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
ABVAX - Profile
Distributions
- YTD Total Return 20.7%
- 3 Yr Annualized Total Return 18.9%
- 5 Yr Annualized Total Return 13.5%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio 0.90%
- Dividend Yield 0.9%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameAB Large Cap Value Fund
-
Fund Family NameALLIANCEBE
-
Inception DateMay 01, 2001
-
Shares OutstandingN/A
-
Share ClassA
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerCem Inal
Fund Description
ABVAX - Performance
Return Ranking - Trailing
| Period | ABVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 20.7% | -1.1% | 43.5% | 4.45% |
| 1 Yr | 31.9% | -0.7% | 71.6% | 5.83% |
| 3 Yr | 18.9%* | -1.2% | 34.0% | 12.71% |
| 5 Yr | 13.5%* | 1.1% | 24.8% | 7.95% |
| 10 Yr | 11.1%* | 3.8% | 27.5% | 55.11% |
* Annualized
Return Ranking - Calendar
| Period | ABVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 6.6% | -43.6% | 32.4% | 49.15% |
| 2024 | 3.3% | -34.7% | 47.5% | 64.09% |
| 2023 | 12.9% | -16.9% | 46.1% | 14.63% |
| 2022 | -17.8% | -43.2% | 4.6% | 88.85% |
| 2021 | 15.2% | -44.1% | 57.5% | 56.04% |
Total Return Ranking - Trailing
| Period | ABVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 20.7% | -1.1% | 43.5% | 4.45% |
| 1 Yr | 31.9% | -0.7% | 71.6% | 5.83% |
| 3 Yr | 18.9%* | -1.2% | 34.0% | 12.71% |
| 5 Yr | 13.5%* | 1.1% | 24.8% | 7.95% |
| 10 Yr | 11.1%* | 3.8% | 27.5% | 55.11% |
* Annualized
Total Return Ranking - Calendar
| Period | ABVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 16.7% | -0.4% | 32.7% | 33.58% |
| 2024 | 15.6% | -17.4% | 47.5% | 35.59% |
| 2023 | 18.5% | -15.9% | 46.7% | 11.45% |
| 2022 | -7.0% | -42.0% | 8.5% | 63.45% |
| 2021 | 27.0% | 6.9% | 129.7% | 38.74% |
NAV & Total Return History
ABVAX - Holdings
Concentration Analysis
| ABVAX | Category Low | Category High | ABVAX % Rank | |
|---|---|---|---|---|
| Net Assets | 529 M | 2.62 M | 254 B | 68.01% |
| Number of Holdings | 64 | 2 | 1671 | 67.58% |
| Net Assets in Top 10 | 156 M | 649 K | 47.6 B | 67.37% |
| Weighting of Top 10 | 30.73% | 4.5% | 99.2% | 35.03% |
Top 10 Holdings
- Alphabet Inc 3.88%
- Lam Research Corp 3.64%
- Exxon Mobil Corp 3.60%
- RTX Corp 3.16%
- Bank of America Corp 2.88%
- Micron Technology Inc 2.84%
- Walt Disney Co/The 2.74%
- Merck Co Inc 2.74%
- UnitedHealth Group Inc 2.63%
- NXP Semiconductors NV 2.62%
Asset Allocation
| Weighting | Return Low | Return High | ABVAX % Rank | |
|---|---|---|---|---|
| Stocks | 99.33% | 3.70% | 178.91% | 32.20% |
| Cash | 1.10% | 0.00% | 26.41% | 49.36% |
| Preferred Stocks | 0.00% | 0.00% | 19.50% | 55.51% |
| Other | 0.00% | -1.51% | 19.37% | 59.85% |
| Convertible Bonds | 0.00% | 0.00% | 3.66% | 52.01% |
| Bonds | 0.00% | 0.00% | 127.82% | 52.97% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | ABVAX % Rank | |
|---|---|---|---|---|
| Healthcare | 20.40% | 0.00% | 27.67% | 18.00% |
| Financial Services | 17.02% | 0.00% | 58.05% | 72.95% |
| Industrials | 10.94% | 0.00% | 42.76% | 54.85% |
| Consumer Defense | 9.91% | 0.00% | 34.10% | 31.52% |
| Technology | 9.71% | 0.00% | 54.02% | 58.36% |
| Communication Services | 8.40% | 0.00% | 26.58% | 11.18% |
| Consumer Cyclical | 7.65% | 0.00% | 19.93% | 24.39% |
| Energy | 7.50% | 0.00% | 54.00% | 58.25% |
| Utilities | 4.99% | 0.00% | 27.04% | 42.81% |
| Real Estate | 3.49% | 0.00% | 90.54% | 38.76% |
| Basic Materials | 0.00% | 0.00% | 20.01% | 95.63% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | ABVAX % Rank | |
|---|---|---|---|---|
| US | 99.33% | 3.70% | 178.91% | 25.85% |
| Non US | 0.00% | 0.00% | 26.23% | 66.31% |
ABVAX - Expenses
Operational Fees
| ABVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.89% | 0.03% | 7.64% | 48.94% |
| Management Fee | 0.48% | 0.00% | 1.50% | 32.41% |
| 12b-1 Fee | 0.25% | 0.00% | 1.00% | 39.66% |
| Administrative Fee | N/A | 0.01% | 0.50% | N/A |
Sales Fees
| ABVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | 4.25% | 1.00% | 5.75% | 92.97% |
| Deferred Load | N/A | 0.95% | 4.00% | N/A |
Trading Fees
| ABVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| ABVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 42.00% | 0.00% | 240.00% | 58.22% |
ABVAX - Distributions
Dividend Yield Analysis
| ABVAX | Category Low | Category High | ABVAX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.95% | 0.00% | 16.67% | 32.66% |
Dividend Distribution Analysis
| ABVAX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annual | Annual | Quarterly | Quarterly |
Net Income Ratio Analysis
| ABVAX | Category Low | Category High | ABVAX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | 0.90% | -1.51% | 4.28% | 75.51% |
Capital Gain Distribution Analysis
| ABVAX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 11, 2025 | $0.205 | OrdinaryDividend |
| Dec 11, 2025 | $0.013 | CapitalGainShortTerm |
| Dec 11, 2025 | $1.519 | CapitalGainLongTerm |
| Dec 12, 2024 | $0.189 | OrdinaryDividend |
| Dec 12, 2024 | $0.053 | CapitalGainShortTerm |
| Dec 12, 2024 | $1.855 | CapitalGainLongTerm |
| Dec 12, 2024 | $2.097 | OrdinaryDividend |
| Dec 07, 2023 | $0.194 | OrdinaryDividend |
| Dec 07, 2023 | $0.578 | CapitalGainLongTerm |
| Dec 08, 2022 | $1.937 | OrdinaryDividend |
| Dec 09, 2021 | $1.767 | OrdinaryDividend |
| Dec 10, 2020 | $0.177 | OrdinaryDividend |
| Dec 12, 2019 | $0.215 | OrdinaryDividend |
| Dec 12, 2019 | $0.114 | CapitalGainLongTerm |
| Dec 13, 2018 | $0.489 | CapitalGainLongTerm |
| Dec 13, 2018 | $0.153 | OrdinaryDividend |
| Dec 14, 2017 | $0.163 | OrdinaryDividend |
| Dec 15, 2016 | $0.159 | OrdinaryDividend |
| Dec 17, 2015 | $0.170 | OrdinaryDividend |
| Dec 18, 2014 | $0.211 | OrdinaryDividend |
| Dec 20, 2013 | $0.133 | OrdinaryDividend |
| Dec 20, 2012 | $0.161 | OrdinaryDividend |
| Dec 22, 2011 | $0.126 | OrdinaryDividend |
| Dec 21, 2010 | $0.089 | OrdinaryDividend |
| Dec 22, 2009 | $0.133 | OrdinaryDividend |
| Dec 22, 2008 | $0.243 | OrdinaryDividend |
| Dec 21, 2007 | $0.185 | CapitalGainShortTerm |
| Dec 21, 2007 | $0.759 | CapitalGainLongTerm |
| Dec 21, 2007 | $0.265 | OrdinaryDividend |
| Dec 14, 2006 | $0.011 | CapitalGainShortTerm |
| Dec 14, 2006 | $0.463 | CapitalGainLongTerm |
| Dec 14, 2006 | $0.191 | OrdinaryDividend |
| Dec 16, 2005 | $0.051 | CapitalGainShortTerm |
| Dec 16, 2005 | $0.649 | CapitalGainLongTerm |
| Dec 16, 2005 | $0.196 | OrdinaryDividend |
| Dec 21, 2004 | $0.232 | CapitalGainLongTerm |
| Dec 21, 2004 | $0.143 | OrdinaryDividend |
| Dec 22, 2003 | $0.100 | OrdinaryDividend |
| Dec 23, 2002 | $0.065 | OrdinaryDividend |
| Dec 14, 2001 | $0.048 | OrdinaryDividend |
ABVAX - Fund Manager Analysis
Managers
Cem Inal
Start Date
Tenure
Tenure Rank
Mar 07, 2016
6.24
6.2%
Cem Inal is a portolio manager and Senior Research Analyst for AllianceBernstein L.P.Before joining the firm in 2003 as a research analyst, Inal was a vice president at fusionOne, a communications software provider. Prior to that, he was an engagement manager at McKinsey & Company and a research engineer at Mitsubishi Electric. Inal holds a BSE in electrical engineering from Princeton University and an MBA in financial engineering from Cornell University. Location: New York
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.13 | 86.59 | 8.33 | 6.71 |